NCT02184247View on ClinicalTrials.gov

Bioavailability of Two Sustained-release Theophylline Products in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

May 31, 1998

Conditions
Healthy
Interventions
DRUG

anhydrous theophylline, 350 mg

DRUG

anhydrous theophylline, 300 mg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY